CSANZ Logo
CSANZ Logo
Welcome to the official website of the


CSANZ Logo
CSANZ Logo
Cardiac Society of Australia and New Zealand
CSANZ Logo


CSANZ Logo


CSANZ Logo

contact
links
want to join?
register
search the CSANZ website
search the CSANZ website
     







search the CSANZ website













CSANZ Directory

CSANZ Member Directory

CSANZ Guidelines

Practice Guidelines

Training and Competence

Meetings

What's On and Where

ASM Abstracts Online

News and Views

Newsletter - On the Pulse

Newsletter - CNWG

In the News

Affiliate News
Career Opportunities

Affiliate Member Area

Affiliate Calendar

Affiliate Discussion

Scholarships/ Fellowships

Working Groups


ASM Abstracts

Treatment of Coronary Bifurcation Lesions with "T" and "Y" Stenting: Acute Results and Long Term Clinical Follow-Up.

M.R. Adams, T. Fukutomi, G. J. Blake, M.V. Wainstein, R. Prpic, J. J. Popma.

Department of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts, U.S.A.

Interventional treatment of true bifurcation lesions is controversial, and is associated with a high procedural complication rate. We examined the immediate and long-term results in 33 consecutive bifurcation lesions treated with a "T" or "Y" stenting approach.

Over a 12-month period 1505 patients were treated with intracoronary stent placement. Stenting of true bifurcation lesions was attempted in 72 cases. In 33 cases planned "Y" stenting (11) or "T" stenting (22) was attempted. Platelet glycoprotein IIb/IIIa inhibitors were used in 85% of cases and all patients received aspirin and either ticlopidine or clopidogrel, 24% received 2 weeks of enoxaparin post procedure. The initial procedural results and the long-term clinical outcomes were assessed in these patients.

Procedures were performed in the setting of myocardial infarction in 3 patients, unstable angina in 20 and stable angina in 10. The vessels involved were left main bifurcation in 1, LAD/diagonal in 13, Circumflex/Marginal in 14, and distal RCA bifurcation in 5. Procedural success was obtained in 100% of cases, with an average of 2.85±0.9 stents per lesion. There were two episodes of transient vessel closure, but no other procedural complications. No patients had electrocardiographic evidence of infarction, although 5 patients (16.7%) had a procedure-related increase in CK post-procedure (mean total CK rise 544±310iU/L). The mean clinical follow-up was 7.2±3.4 months. There were no deaths, and 22 (67%) patients were event free at follow-up. There were 3 episodes of in-stent thrombosis occurring within the first month (time to event 8±9 days), and there were 6 cases of restenosis requiring repeat revascularization (2 requiring coronary artery bypass grafts), occurring a mean of 36±39 days post-procedure. There was a significant relationship between diabetes and recurrent cardiovascular events (event rate 80% in diabetics versus 25% in non-diabetics, p=0.01).    Bifurcation stenting with a "T" or "Y" technique is associated with a high rate of procedural and early complications, although the late complication rate is acceptable in non-diabetics. The high rate of late events in diabetic patients suggests that alternative therapies should be considered.

[ Back to 48th ASM Abstract Index ]


Med-E-Serv